Corvus Pharmaceuticals Inc (CRVS)

NASDAQ
4.470
-0.320(-6.68%)
After Hours
4.540
+0.070(+1.566%)
- Real-time Data
  • Volume:
    979,765
  • Bid/Ask:
    4.400/4.800
  • Day's Range:
    4.280 - 4.860

CRVS Overview

Prev. Close
4.79
Day's Range
4.28-4.86
Revenue
-
Open
4.73
52 wk Range
1.86-9.54
EPS
-0.02
Volume
979,765
Market Cap
189.62M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
8,038,563
P/E Ratio
-
Beta
0.94
1-Year Change
11.75%
Shares Outstanding
42,421,159
Next Earnings Date
Mar 10, 2022
What is your sentiment on Corvus Pharmaceuticals Inc?
or
Market is currently closed. Voting is open during market hours.

Corvus Pharmaceuticals Inc News

Corvus Pharmaceuticals Inc Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyNeutralSellNeutralBuy
Technical IndicatorsStrong BuyBuyStrong SellStrong SellNeutral
SummaryStrong BuyNeutralStrong SellSellNeutral

Corvus Pharmaceuticals Inc Company Profile

Corvus Pharmaceuticals Inc Company Profile

Employees
42

Corvus Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of immuno-oncology therapies. The Company is developing drugs and antibodies that block crucial immune checkpoints and reprogram immune T-cells. The Company has a pipeline of four immuno-oncology programs, three of which focus on the adenosine-cancer axis to modulate an immune response. The Company's lead product candidate, CPI-444, is an oral, small molecule antagonist of the A2A receptor for adenosine, an immune checkpoint. Its other products include adenosine production inhibitor (a monoclonal anti-CD73 antibody); adenosine A2B antagonist, and interleukin-2 (IL-2)-inducible T cell kinase (ITK) inhibitors. As of September 30, 2016, the Company had not generated any revenue.

Read More
  • .
    1
    • .
      0
      • .m
        0
        • .
          0
          • .
            0
            • 99% bull Monday morning
              0
              • @ do you think Tarbin will go down on Monday or more up ?
                0
            • might go down on Monday after 10-11am
              0
              • u got it.
                0
                • Let's go bro
                  0
                  • keep going down
                    0
                    • Bought in at 5.27
                      2
                      • 5.25 bought :(
                        1
                        • Don't worry it will rise tomorrow
                          0
                      • wow.. whats next
                        0
                        • no next hahah making money only
                          0
                      Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                      Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.